Sarcopenia and CRP-TyG Index (CTI) as Predictors of Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer

NCT07192926 · clinicaltrials.gov ↗

COMPLETED

Status

131

Enrollment

OTHER_GOV

Sponsor class

Conditions

Metastatic Non-small Cell Lung Cancer
Neoplasm

Interventions

DRUG: Immune Checkpoint Inhibitors

Sponsor

Ankara Etlik City Hospital